We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+3.36%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$4.51B
AUM Growth
+$737M
Cap. Flow
+$736M
Cap. Flow %
16.32%
Top 10 Hldgs %
19.25%
Holding
501
New
284
Increased
70
Reduced
66
Closed
74

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$99.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.8M
3
MDT icon
Medtronic
MDT
+$68.7M
4
NXPI icon
NXP Semiconductors
NXPI
+$61.6M
5
LITE icon
Lumentum
LITE
+$58.9M

Sector Composition

Rank Sector Weight
1 Healthcare 47.83%
2 Technology 26.25%
3 Communication Services 6.68%
4 Consumer Discretionary 4.05%
5 Financials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARGX icon
301
argenx
ARGX
$54.3B
$1.8M 0.04%
+6,540
New +$2.07M
POSH
302
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$1.78M 0.04%
+43,822
New +$2.68M
COTY icon
303
Coty
COTY
$2.49B
$1.76M 0.04%
195,948
-365,485
-65% -$2.79M
DOCN icon
304
DigitalOcean
DOCN
$14.6B
$1.76M 0.04%
+41,844
New +$1.73M
HSKA
305
DELISTED
Heska Corp
HSKA
$1.76M 0.04%
+10,462
New +$1.86M
DSEY
306
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
$1.75M 0.04%
+119,334
New +$1.77M
EJFAU
307
DELISTED
EJF Acquisition Corp. Unit
EJFAU
$1.74M 0.04%
+175,000
New +$1.75M
VPCBU
308
DELISTED
VPC Impact Acquisition Holdings II Unit
VPCBU
$1.73M 0.04%
+175,000
New +$1.75M
LVTX
309
DELISTED
LAVA Therapeutics
LVTX
$1.72M 0.04%
+113,242
New +$1.56M
QDROU
310
DELISTED
Quadro Acquisition One Corp. Unit
QDROU
$1.71M 0.04%
+172,066
New +$1.72M
VINP icon
311
Vinci Compass Investments Ltd
VINP
$648M
$1.71M 0.04%
+129,917
New +$2.11M
TZPS
312
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
$1.7M 0.04%
+175,000
New +$1.71M
CD
313
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$1.69M 0.04%
101,964
+5,998
+6% +$113K
CPUH.U
314
DELISTED
Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
CPUH.U
$1.62M 0.04%
+160,170
New +$1.68M
MORF
315
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$1.58M 0.04%
+24,909
New +$1.14M
PHAT icon
316
Phathom Pharmaceuticals
PHAT
$666M
$1.56M 0.03%
+41,678
New +$1.74M
THMAU
317
DELISTED
Thimble Point Acquisition Corp. Unit
THMAU
$1.5M 0.03%
+150,104
New +$1.53M
BYTSU
318
DELISTED
BYTE Acquisition Corp. Units
BYTSU
$1.5M 0.03%
+150,000
New +$1.5M
GIIXU
319
DELISTED
Gores Holdings VIII, Inc. Unit
GIIXU
$1.5M 0.03%
+150,000
New +$1.52M
APGB.U
320
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
$1.5M 0.03%
+150,000
New +$1.54M
FACT.U
321
DELISTED
Freedom Acquisition I Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
FACT.U
$1.5M 0.03%
+150,000
New +$1.5M
SCOBU
322
DELISTED
ScION Tech Growth II Units
SCOBU
$1.49M 0.03%
+150,000
New +$1.54M
NSTC.U
323
DELISTED
Northern Star Investment Corp. III Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTC.U
$1.49M 0.03%
+150,000
New +$1.5M
SSAAU
324
DELISTED
Science Strategic Acquisition Corp. Alpha Unit
SSAAU
$1.49M 0.03%
+150,000
New +$1.54M
HYACU
325
DELISTED
Haymaker Acquisition Corp. III Unit
HYACU
$1.49M 0.03%
+150,000
New +$1.5M

Similar funds

Woodline Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Woodline Partners held 501 positions worth $4.51B, up 20% from $3.77B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Woodline Partners deployed $736M of net new capital in Q1 2021, opening 284 new positions and adding to 70 existing holdings. Its largest new stake was Gilead Sciences: 1,541,893 shares worth $99.7M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 43% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Amgen, an estimated $99.3M trimmed.

  • Woodline Partners's largest Q1 2021 buy was Gilead Sciences: 1,541,893 shares worth $99.7M.
  • Woodline Partners added most to Regeneron Pharmaceuticals in Q1 2021, an estimated $80.7M increase.
  • Woodline Partners's biggest Q1 2021 reduction was Amgen, cutting an estimated $99.3M.
  • Woodline Partners fully exited Alphabet (Google) Class A in Q1 2021, selling an estimated $97.8M.
  • Woodline Partners's ten largest holdings make up 19% of its $4.51B portfolio in Q1 2021.
  • Woodline Partners opened 284 new positions and closed 74 in Q1 2021.
  • Woodline Partners's portfolio value rose 20% quarter-over-quarter to $4.51B.

Based on Woodline Partners's 13F filing for Q1 2021, filed 17 May 2021.